TOKU-E Company Revenue and Competitors
Estimated Revenue & Valuation
- TOKU-E Company's estimated annual revenue is currently $5.1M per year.
- TOKU-E Company's estimated revenue per employee is $155,000
Employee Data
- TOKU-E Company has 33 Employees.
- TOKU-E Company grew their employee count by 0% last year.
TOKU-E Company's People
Name | Title | Email/Phone |
---|---|---|
1 | Global Sales and Marketing Director | Reveal Email/Phone |
2 | Product Manager | Reveal Email/Phone |
3 | Allround Administrative Assistant | Reveal Email/Phone |
4 | Scientific Researcher | Reveal Email/Phone |
TOKU-E Company Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is TOKU-E Company?
TOKU-E Company specializes in the development and manufacturing of ultra-pure antibiotics and fine chemicals for life sciences research, not for human or animal use. Through cutting edge technology and human ingenuity, TOKU-E is able to facilitate the advancement of cell- micro- and plant biology. Holding true to its uncompromising standard of precision and perfection, TOKU-E has positioned itself as a global leader in biotechnology innovation with great benefits and applications for biotechnology research scientific communities.
keywords:N/AN/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 33 | 10% | N/A |
#2 | N/A | 33 | 6% | N/A |
#3 | $1.7M | 33 | 6% | N/A |
#4 | $7.9M | 34 | 6% | N/A |
#5 | $7.9M | 34 | 10% | N/A |